iShares Biotechnology ETF
IBB
IBB
232 hedge funds and large institutions have $2.26B invested in iShares Biotechnology ETF in 2013 Q2 according to their latest regulatory filings, with 232 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
232
Holders Change
+232
Holders Change %
–
% of All Funds
7.57%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
%
% of All Funds
0.33%
New
232
Increased
–
Reduced
–
Closed
–
Calls
$127M
Puts
$212M
Net Calls
-$85.3M
Net Calls Change
-$85.3M
Top Buyers
1 |
1
Morgan Stanley
New York
|
$268M |
2 |
2
Goldman Sachs
New York
|
$263M |
3 |
3
Bank of America
Charlotte,
North Carolina
|
$214M |
4 |
4
Citigroup
New York
|
$180M |
5 |
5
Allianz Asset Management
Munich,
Germany
|
$124M |
Top Sellers
No sellers this quarter